OX
Oxford BioMedica
OXB.L·LSEOxford UKFounded 1995600 employees
Small CapbiotechPublicGenetic Medicine
Platform: LentiVector
Market Cap
$0.5B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (OXB.L)
Loading OXB.L stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Datorelsin | OXB-4197 | NDA/BLA | 1 | PRMT5 | PSP | ||
| Cevirapivir | OXB-8812 | Approved | 3 | SOS1 | HCC |
SEC Filings & Financial Documents
SEC filings are not available for LSE-listed companies.
Oxford BioMedica trades on LSE (GB). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)